VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,449,000 | +77.2% | 4,332 | -97.6% | 3.31% | -11.3% |
Q4 2021 | $5,897,000 | +178.9% | 184,118 | +156.7% | 3.73% | +178.2% |
Q3 2021 | $2,114,000 | -72.1% | 71,738 | -65.9% | 1.34% | -67.5% |
Q4 2020 | $7,569,000 | -77.0% | 210,137 | -86.0% | 4.12% | -36.2% |
Q1 2018 | $32,970,000 | +1173.0% | 1,500,000 | +1660.5% | 6.46% | -45.0% |
Q3 2016 | $2,590,000 | +7.3% | 85,205 | +581.6% | 11.75% | +151.0% |
Q2 2016 | $2,414,000 | – | 12,500 | – | 4.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |